Champignon Brands Inc. (SHRM)

Champignon Brands Logo White

Champignon Brands

CSE: SHRM | OTC: SHRMF | FWB: 496

Champignon Brands is a publicly-traded, research-driven company active in the formulation and production of a variety of psychedelic medicines and products.

The Company has been subject to a Continuous Disclosure Review by the BC Securities Commission, and as such SHRM shares are currently under a Cease Trade Order. 

Champignon Brands (USD)
$0.4801
-11.09%
$0.0600

Exclusive Interview

We spoke with Dr. Roger McIntyre, CEO of Champignon Brands, about his immediate and future plans for the company…

Read the full interview

Latest News

Champignon Brands Updates Investors on Changes at the Top

November 24, 2020

Canadian Rapid Treatment Center of Excellence Opens Second Location Providing Ketamine Treatment for Adults with Depression

November 9, 2020

Champignon Brands Provides Update on Continuous Disclosure Review

October 29, 2020

Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

October 5, 2020

Champignon Provides Update on Disclosure Review

September 15, 2020

Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

August 27, 2020

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.